Quantum Biopharma Ltd. Files 6-K, Incorporates Exhibit
Ticker: QNTM · Form: 6-K · Filed: Aug 16, 2024 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Aug 16, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, registration-statement, corporate-update
TL;DR
Quantum Biopharma (QNTB) filed a 6-K, incorporating an exhibit into its F-3. Standard update.
AI Summary
Quantum Biopharma Ltd. (formerly FSD Pharma Inc.) filed a Form 6-K on August 16, 2024, incorporating by reference Exhibit 3.1 into its existing Form F-3 Registration Statement (SEC File No. 333-276264). The company, based in Toronto, Canada, operates in the Pharmaceutical Preparations sector.
Why It Matters
This filing indicates ongoing regulatory compliance and updates to the company's registration statement, which could be relevant for investors tracking its financial and legal disclosures.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that incorporates an exhibit into an existing registration statement, with no new material financial or operational information disclosed.
Key Players & Entities
- Quantum Biopharma Ltd. (company) — Registrant
- FSD Pharma Inc. (company) — Former company name
- August 16, 2024 (date) — Filing date
- Form F-3 (document) — Incorporated into
- 333-276264 (document) — SEC File Number for Form F-3
- Toronto, Ontario (location) — Company headquarters
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report information and incorporate by reference Exhibit 3.1 into the Registrant's Registration Statement on Form F-3 (SEC File No. 333-276264).
What was Quantum Biopharma Ltd. formerly known as?
Quantum Biopharma Ltd. was formerly known as FSD Pharma Inc.
When was the company's name changed?
The date of the name change from FSD Pharma Inc. to Quantum Biopharma Ltd. was March 27, 2019.
Where is Quantum Biopharma Ltd. located?
Quantum Biopharma Ltd.'s principal executive office is located at 199 Bay St., Suite 4000, Toronto, Ontario, Canada.
What is the SIC code for Quantum Biopharma Ltd.?
The Standard Industrial Classification (SIC) code for Quantum Biopharma Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 338 words · 1 min read · ~1 pages · Grade level 11.8 · Accepted 2024-08-15 20:15:04
Filing Documents
- fsd_6k.htm (6-K) — 12KB
- fsd_ex31.htm (EX-3.1) — 3KB
- fsd_ex31img5.jpg (GRAPHIC) — 109KB
- fsd_ex31img6.jpg (GRAPHIC) — 107KB
- fsd_ex31img7.jpg (GRAPHIC) — 78KB
- fsd_ex31img8.jpg (GRAPHIC) — 41KB
- 0001654954-24-010765.txt ( ) — 478KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Quantum BioPharma Ltd. (Registrant) Date: August 15, 2024 By: /s/ Nathan Coyle Nathan Coyle, Chief Financial Officer 3 EXHIBIT INDEX Exhibit Description Exhibit 3.1 Certificate of Amendment and Articles of Amendment, effective August 15, 2024 4